GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Additional Paid-In Capital

China Pharma Holding (STU:XQJ0) Additional Paid-In Capital : €34.13 Mil(As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Additional Paid-In Capital?


China Pharma Holding's quarterly additional paid-in capital increased from Sep. 2023 (€30.68 Mil) to Dec. 2023 (€32.35 Mil) and increased from Dec. 2023 (€32.35 Mil) to Mar. 2024 (€34.13 Mil).

China Pharma Holding's annual additional paid-in capital increased from Dec. 2021 (€22.70 Mil) to Dec. 2022 (€27.31 Mil) and increased from Dec. 2022 (€27.31 Mil) to Dec. 2023 (€32.35 Mil).


China Pharma Holding Additional Paid-In Capital Historical Data

The historical data trend for China Pharma Holding's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Additional Paid-In Capital Chart

China Pharma Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.23 20.10 22.70 27.31 32.35

China Pharma Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.55 27.96 30.68 32.35 34.13

China Pharma Holding Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

China Pharma Holding Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


China Pharma Holding (STU:XQJ0) Business Description

Traded in Other Exchanges
Address
Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines